Prostate cancer death rates decreased among US males from 1999 to 2017

This observational analysis used US vital statistics data from 1999 to 2017 to examine trends in prostate cancer mortality. The study population included males in the United States, though the specific sample size was not reported. No specific intervention, exposure, or comparator was examined; the analysis focused on descriptive trends in age-adjusted death rates.

The primary finding was a decrease in the age-adjusted prostate cancer death rate among all males, from 31.3 per 100,000 in 1999 to 18.7 per 100,000 in 2017. No effect size, p-values, or confidence intervals were reported for this change. Safety, tolerability, and adverse event data were not reported, as this was a population-level mortality analysis.

Key limitations include the purely observational and descriptive nature of the data, which prevents any causal inference about what factors drove the decline. The funding source and potential conflicts of interest were not reported. The practice relevance is restrained; this data describes a population-level trend over nearly two decades but does not inform specific clinical decisions for individual patients.